[1]Tseng,ChristopherK.H.;Marquez,VictorE.;Fuller,RichardW.;Goldstein,BarryM.;Haines,DavidR.;etal.[JournalofMedicinalChemistry,1989,vol.32,#7,p.1442-1446]
[1]Tseng,ChristopherK.H.;Marquez,VictorE.;Fuller,RichardW.;Goldstein,BarryM.;Haines,DavidR.;etal.[JournalofMedicinalChemistry,1989,vol.32,#7,p.1442-1446]
[1]JournalofMedicinalChemistry,1989,vol.32,p.1442-1446
[1]Tseng,ChristopherK.H.;Marquez,VictorE.;Fuller,RichardW.;Goldstein,BarryM.;Haines,DavidR.;etal.[JournalofMedicinalChemistry,1989,vol.32,#7,p.1442-1446]
[1]Tseng,ChristopherK.H.;Marquez,VictorE.;Fuller,RichardW.;Goldstein,BarryM.;Haines,DavidR.;etal.[JournalofMedicinalChemistry,1989,vol.32,#7,p.1442-1446]
Title: [Role of adrenergic mechanisms in origin of arrhythmias following administration of tricyclic antidepressive agents].
Journal: Deutsche medizinische Wochenschrift (1946) 19760116
Title: Fiskus W, et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor LBH589 against human AML cells. Blood, 2009, 114(13), 2733-2743.
Title: Avan A, et al. Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with LY 188011 in pancreatic cancer cells. Mol Cancer Ther. 2012 Aug;11(8):1735-46.
Title: Kikuchi J, et al. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer. 2012 Nov;78(2):138-43.
Title: Sun F, et al. Preclinical pharmacokinetic studies of 3-deazaneplanocin A, a potent epigenetic anticancer agent, and its human pharmacokinetic prediction using GastroPlus?. Eur J Pharm Sci. 2015 Sep 18;77:290-302.
Title: Noriko Uchiyama, et al. Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a. Eur J Pharmacol. 2017 Oct 5;812:138-146.
Title: Robert O Baker, et al. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 2003 Jan;57(1-2):13-23.
